Business Wire | Jul 15, 2020 04:30PM EDT

ResMed to Report Fourth Quarter Fiscal 2020 Earnings on August 5, 2020

Jul. 15, 2020

SAN DIEGO--(BUSINESS WIRE)--Jul. 15, 2020--ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2020 on Wednesday, August 5, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.

Earnings webcast details:

? Location: http://investor.resmed.com

? Date: Wednesday, August 5, 2020

? Time: 1:30 p.m. PDT / 4:30 p.m. EDT

? International: London, Wednesday, August 5, 9:30 p.m. BST

Sydney, Thursday, August 6, 6:30 a.m. AEST

Please note that ResMed does not use outside phone lines to access the earnings call.

A replay of the earnings webcast will be accessible on ResMed's website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from August 5 until August 19 at:

* U.S.: +1 833.241.4253 * International: +1 647.689.4204 * Conference ID: 2498310

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005039/en/

CONTACT: For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com

CONTACT: For media Jayme Rubenstein +1 858.836.6798 news@resmed.com